Parties d'ouvrages collectifs (1)
  1. 1. Flamand, V., & Goldman, M. (2006). Role of dendritic cells in graft rejection and graft-versus-Host disease. In M. B. Lutz, N. Romani, & A. Steinkasserer (Eds.), Handbook of dendritic cells (pp. 967-982). WILEY-VCH Verlag GmbH & Co.
    2.   Articles dans des revues avec comité de lecture (82)
  2. 1. Radwanska, M., de Lemos Esteves, F., Linsen, L., Coltel, N., Cencig, S., Widart, J. J., Massart, A., Colson, S., Di Paolo, A., Percier, P., Ait Djebbara, S., Guillonneau, F., Flamand, V., De Pauw, E., Frere, J.-L., Carlier, Y., & Truyens (Co-dernier auteur), C. (2023). Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice. Frontiers in immunology, 14, 1138526. doi:10.3389/fimmu.2023.1138526
  3. 2. Dauby, N., & Flamand, V. (2022). From maternal breath to infant's cells: Impact of maternal respiratory infections on infants ‘immune responses. Frontiers in Pediatrics, 10. doi:10.3389/fped.2022.1046100
  4. 3. Smout, J., Valentin, C., Delbauve, S., Pauwels, J., Köhler, A., & Flamand, V. (2022). Maternal Lactobacillus rhamnosus administration impacts neonatal CD4 T-cell activation and prevents murine T helper 2-type allergic airways disease. Frontiers in immunology, 13, 1082648. doi:10.3389/fimmu.2022.1082648
  5. 4. Celus, W., Oliveira, A. A., Rivis, S., Van Acker, H., Landeloos, E., Serneels, J., Cafarello, S. T., Van Herck, Y., Mastrantonio, R., Kohler, A., Garg, A. A., Flamand, V., Tamagnone, L., Marine, J.-C., Di Matteo, M., Costa, B., Bechter, O., & Mazzone, M. (2022). Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer. Cancer immunology research, 10(1), 126-141. doi:10.1158/2326-6066.CIR-21-0061
  6. 5. Demars, A., Vitali, A., Comein, A., Carlier, E., Azouz, A., Goriely, S., Smout, J., Flamand, V., van Gysel, M., Wouters, J., Abendroth, J., Edwards, T. T., Machelart, A., Hoffmann, E., Brodin, P., De Bolle, X., & Muraille, E. (2021). Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice. P L o S Pathogens, 17(9), e1009887. doi:10.1371/journal.ppat.1009887
  7. 6. Germanova, D., Keirsse, J., Köhler, A., Hastir, J.-F., Demetter, P., Delbauve, S., Elkrim, Y., Verset, L., Larbanoix, L., Preyat, N., Laurent, S., Nedospasov, S., Donckier, V., Van Ginderachter, J. A., & Flamand, V. (2020). Myeloid tumor necrosis factor and heme oxygenase-1 regulate the progression of colorectal liver metastases during hepatic ischemia-reperfusion. International journal of cancer. doi:10.1002/ijc.33334
  8. 7. Hastir, J.-F., Delbauve, S., Larbanoix, L., Germanova, D., Goyvaerts, C., Allard, J., Laurent, S., Breckpot, K., Beschin, A., Guilliams, M., & Flamand, V. (2020). Hepatocarcinoma Induces a Tumor Necrosis Factor-Dependent Kupffer Cell Death Pathway That Favors Its Proliferation Upon Partial Hepatectomy. Frontiers in oncology, 10. doi:10.3389/fonc.2020.547013
  9. 8. Köhler, A., Delbauve, S., Smout, J., Torres, D., & Flamand, V. (2020). Very early-life exposure to microbiota-induced TNF drives the maturation of neonatal pre-cDC1. Gut. doi:10.1136/gutjnl-2019-319700
  10. 9. Spilleboudt, C., De Wilde, V., Lewalle, P., Cabanne, L., Leclerc, M., Beckerich, F., Bories, D., Cardoso, S., Soares, M. P., Vokaer, B., Hougardy, J.-M., Flamand, V., Racapé, J., Abramowicz, M., Maury, S., & Le Moine, A. (2020). Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease. Frontiers in immunology, 11, 579151. doi:10.3389/fimmu.2020.579151
  11. 10. Rossi, M., Delbauve, S., Roumeguere, T., Wespes, E., Leo, O., Flamand, V., Le Moine, A., & Hougardy, J.-M. (2019). HO-1 mitigates acute kidney injury and subsequent kidney-lung cross-talk. Free radical research, 53(9-10), 1035-1043. doi:10.1080/10715762.2019.1668936
  12. 11. Rossi, M., Delbauve, S., Wespes, E., Roumeguere, T., Leo, O., Flamand, V., Le Moine, A., & Hougardy, J.-M. (2018). Dual effect of hemin on renal ischemia-reperfusion injury. Biochemical and biophysical research communications, 503(4), 2820-2825. doi:10.1016/j.bbrc.2018.08.046
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>